Healthcare provider profile · identity verified

John Christopher Baniewicz, MD

Internal Medicine · MENTOR, OH · NPI 1609372531

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	944	283
Amlodipine Besylate	Amlodipine Besylate	907	267
Levothyroxine Sodium	Levothyroxine Sodium	695	194
Losartan Potassium	Losartan Potassium	672	191
Lisinopril	Lisinopril	637	184
Simvastatin	Simvastatin	529	151
Omeprazole	Omeprazole	500	161
Metformin Hcl Er	Metformin Hcl	460	144
Rosuvastatin Calcium	Rosuvastatin Calcium	430	133
Metoprolol Succinate	Metoprolol Succinate	420	131
Hydrochlorothiazide	Hydrochlorothiazide	382	117
Furosemide	Furosemide	369	118
Gabapentin	Gabapentin	363	101
Tamsulosin Hcl	Tamsulosin Hcl	359	112
Metformin Hcl	Metformin Hcl	331	94
Sertraline Hcl	Sertraline Hcl	305	84
Metoprolol Tartrate	Metoprolol Tartrate	264	76
Eliquis	Apixaban	257	69
Ozempic	Semaglutide	242	37
Pantoprazole Sodium	Pantoprazole Sodium	242	69
Pravastatin Sodium	Pravastatin Sodium	222	67
Allopurinol	Allopurinol	206	65
Jardiance	Empagliflozin	200	43
Meloxicam	Meloxicam	192	63
Carvedilol	Carvedilol	162	49
Mounjaro	Tirzepatide	158	25
Albuterol Sulfate Hfa	Albuterol Sulfate	157	66
Potassium Chloride	Potassium Chloride	152	51
Atenolol	Atenolol	144	45
Clopidogrel	Clopidogrel Bisulfate	137	42
Trulicity	Dulaglutide	137	18
Synthroid	Levothyroxine Sodium	133	42
Zolpidem Tartrate	Zolpidem Tartrate	129	37
Duloxetine Hcl	Duloxetine Hcl	127	43
Tramadol Hcl	Tramadol Hcl	123	25
Warfarin Sodium	Warfarin Sodium	117	29
Escitalopram Oxalate	Escitalopram Oxalate	109	38
Lovastatin	Lovastatin	109	33
Citalopram Hbr	Citalopram Hydrobromide	107	30
Tizanidine Hcl	Tizanidine Hcl	107	46
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	101	31
Alendronate Sodium	Alendronate Sodium	99	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	94	34
Alprazolam	Alprazolam	93	21
Finasteride	Finasteride	92	24
Chlorthalidone	Chlorthalidone	91	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	26
Lorazepam	Lorazepam	79	21
Trazodone Hcl	Trazodone Hcl	76	28
Fluoxetine Hcl	Fluoxetine Hcl	73	18
Glimepiride	Glimepiride	73	24
Torsemide	Torsemide	64	18
Farxiga	Dapagliflozin Propanediol	62	18
Pioglitazone Hcl	Pioglitazone Hcl	61	22
Breo Ellipta	Fluticasone/Vilanterol	57	12
Buspirone Hcl	Buspirone Hcl	57	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Xarelto	Rivaroxaban	52	suppressed
Fenofibrate	Fenofibrate	51	12
Azithromycin	Azithromycin	50	47
Bupropion Xl	Bupropion Hcl	50	16
Ezetimibe	Ezetimibe	49	17
Spironolactone	Spironolactone	49	17
Ramipril	Ramipril	47	13
Famotidine	Famotidine	46	17
Glipizide	Glipizide	43	18
Fluticasone Propionate	Fluticasone Propionate	42	19
Montelukast Sodium	Montelukast Sodium	42	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	15
Paroxetine Hcl	Paroxetine Hcl	41	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	14
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	suppressed
Donepezil Hcl	Donepezil Hcl	37	12
Clonidine Hcl	Clonidine Hcl	36	suppressed
Glipizide Er	Glipizide	35	12
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Vascepa	Icosapent Ethyl	33	suppressed
Diazepam	Diazepam	32	suppressed
Digoxin	Digoxin	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	32	14
Pregabalin	Pregabalin	32	suppressed
Creon	Lipase/Protease/Amylase	31	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Lacosamide	Lacosamide	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Celecoxib	Celecoxib	29	12
Klor-Con M20	Potassium Chloride	29	13
Irbesartan	Irbesartan	28	suppressed
Phenobarbital	Phenobarbital	28	suppressed
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Acyclovir	Acyclovir	27	13
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	14
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Prednisone	Prednisone	26	16
Terazosin Hcl	Terazosin Hcl	26	suppressed
Jantoven	Warfarin Sodium	25	suppressed
Temazepam	Temazepam	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Cephalexin	Cephalexin	23	19
Memantine Hcl	Memantine Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	18
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	18
Indapamide	Indapamide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Colchicine	Colchicine	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	19	15
Propranolol Hcl	Propranolol Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Topiramate	Topiramate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Methimazole	Methimazole	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error